The treatment of combination chemotherapy-resistant Hodgkin disease with single-agent vinblastine
โ Scribed by Robert D. Warren; Dr Richard A. Bender; Larry Norton; Robert C. Young
- Publisher
- John Wiley and Sons
- Year
- 1978
- Tongue
- English
- Weight
- 539 KB
- Volume
- 4
- Category
- Article
- ISSN
- 0361-8609
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
Optimal treatment for Hodgkin's disease during childhood is unknown. We report the treatment outcome of patients with Hodgkin's disease โค13 years of age seen at the American University of Beirut Medical Center (AUBMC) between 1980 and 1996. A retrospective review of the medical records of 24 childre
Eighteen children with Hodgkin disease ( 16previously untreated; two relapsed) were treated with MOPP chemotherapy (nitrogen mustard, vincristine, prednisone, procarbazine) only. Ten had clinical stage I and II disease, four had stage Ill, and four had stage IV. In ten patients, the clinical stage w
The drug combination of mitomycin-C, cisplatin, and vinblastine was administered to 30 patients with stage III non-small-cell lung cancer. All patients had a performance status of 50% or greater, had evaluable disease, and had not received previous chemotherapy. The overall response rate was 37% wit